Knight Cancer Institute at Oregon Health Sciences University (OHSU)

Site:	Knight Cancer Institute at Oregon Health Sciences University (OHSU)	Go to their website
Address:	3181 S.W. Sam Jackson Park Rd.
City:	Portland
State:	OR
Zip:	97239
Country:	USA

Phase	Trial [asc]	Trial Status	Site Status	Drug	NCT#
3	Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib	Terminated	Closed	IPI-504	NCT00688766
3	Study of Regorafenib as a 3rd-line or Greater Treatment for Gastrointestinal Stromal Tumors (GIST) (GRID)	Ongoing, but not recruiting	Closed	Regorafenib (BAY 73-4506)	NCT01271712
2	Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor	Active, not recruiting	Active	Temozolomide	NCT03556384
3	(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST	Active, not recruiting	Active	Avapritinib or Regorafenib	NCT03465722